These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32038904)

  • 1. A curious case of de novo anti-HLA-C antibody-mediated humoral rejection and Fabry-like zebra bodies in a renal transplant recipient.
    Abuzeineh M; Ziadeh A; Kheradmand T; Nguyen V; Yerram P
    Clin Nephrol Case Stud; 2020; 8():12-16. PubMed ID: 32038904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-Mediated Rejection Due to Preexisting versus
    Aubert O; Loupy A; Hidalgo L; Duong van Huyen JP; Higgins S; Viglietti D; Jouven X; Glotz D; Legendre C; Lefaucheur C; Halloran PF
    J Am Soc Nephrol; 2017 Jun; 28(6):1912-1923. PubMed ID: 28255002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunological relevance of antibodies in solid organ transplantation.
    Mehra NK; Baranwal AK
    Int J Immunogenet; 2016 Dec; 43(6):351-368. PubMed ID: 27870356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of
    Chowdhry M; Patel M; Thakur Y; Sharma V
    Asian J Transfus Sci; 2019; 13(2):136-139. PubMed ID: 31896922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the Role of Allo-Antibodies and Transplant Injury.
    Matsuda Y; Sarwal MM
    Front Immunol; 2016; 7():432. PubMed ID: 27818660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histopathologic features of antibody-mediated rejection among pediatric renal transplant recipients with preformed vs de novo donor-specific antibodies.
    Steggerda JA; Kim IK; Haas M; Zhang X; Kang A; Pizzo H; Kamil E; Jordan S; Puliyanda D
    Pediatr Transplant; 2017 Dec; 21(8):. PubMed ID: 29159992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated rejection due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient.
    Sagasaki M; Nakada Y; Yamamoto I; Kawabe M; Yamakawa T; Katsumata H; Mafune A; Katsuma A; Kobayashi A; Koike K; Koike Y; Miki J; Yamada H; Kimura T; Tanno Y; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():81-84. PubMed ID: 29968405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower incidence of de novo donor-specific antibodies against HLA-DR in ABO-incompatible renal transplantation.
    Okada M; Watarai Y; Iwasaki K; Futamura K; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Narumi S; Takeda A; Kobayashi T
    Hum Immunol; 2019 Mar; 80(3):169-175. PubMed ID: 30552908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Mazanowska O; Krajewska M; Zabińska M; Bartoszek D; Myszka M; Nowakowska B; Dawiskiba T; Lepiesza A; Chudoba P; Klinger M
    Transplant Proc; 2013 May; 45(4):1449-52. PubMed ID: 23726594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population.
    Banasik M; Kościelska-Kasprzak K; Myszka M; Bartoszek D; Zabińska M; Boratyńska M; Kamińska D; Mazanowska O; Zmonarski S; Krajewska M; Hałoń A; Dawiskiba T; Nowakowska B; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2613-7. PubMed ID: 25380878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation.
    Caro-Oleas JL; González-Escribano MF; Gentil-Govantes MÁ; Acevedo MJ; González-Roncero FM; Blanco GB; Núñez-Roldán A
    Transplantation; 2012 Aug; 94(4):338-44. PubMed ID: 22814330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
    Pandey S; Harville TO
    Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
    Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study.
    Babu A; Andreou A; Briggs D; Krishnan N; Higgins R; Mitchell D; Barber T; Daga S
    Clin Transpl; 2016; 32():173-179. PubMed ID: 28564535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients.
    de Sousa MV; Gonçalez AC; Zollner RL; Mazzali M
    Ann Transplant; 2018 Jul; 23():457-466. PubMed ID: 29976918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody.
    Suneja M; Kuppachi S
    Clin Kidney J; 2012 Jun; 5(3):254-6. PubMed ID: 26069779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case report.
    Cippà PE; Gaspert A; Etter C; Guenduez Z; Ferrari-Lacraz S; Rüsi B; Fehr T
    Hum Immunol; 2014 May; 75(5):462-5. PubMed ID: 24530822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.